• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Large Pharma

Daiichi Sankyo Co Ltd

+ Add to Watchlist


12.970 EUR 0.475 3.53%

As of 02:17:20 ET on 09/17/2014.

Snapshot for Daiichi Sankyo Co Ltd (D4S)

Open: 12.935 Day's Range: 12.901 - 13.205 Volume: 0
Previous Close: 13.445 52wk Range: 11.380 - 14.640 1-Yr Rtn: +0.18%

Stock Chart for D4S

No chart data available.
  • D4S:GR 13.205
  • 1D
  • 1M
  • 1Y
Interactive D4S Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for D4S

Current P/E Ratio (ttm) -
Estimated P/E(03/2015) 16.6328
Relative P/E vs. DAX -
Earnings Per Share (JPY) (ttm) -
Est. EPS (JPY) (03/2015) 108.4510
Est. PEG Ratio 7.2003
Market Cap (M EUR) 9,195.88
Shares Outstanding (M) 709.01
30 Day Average Volume 9
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 3.33%
Cash Dividend (JPY) 30.0000
Dividend Ex-Date 09/26/2014
5 Year Dividend Growth -4.68%
Next Earnings Announcement 10/31/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for D4S

  • Revenue
  • Net Income (M/JPY)
  • Profit Margin (%)

Company Profile & Key Executives for D4S

DAIICHI SANKYO COMPANY, LIMITED is a holding company established through merger of Sankyo and Daiichi pharmaceutical. The Group manufactures pharmaceuticals for human/veterinary use and medical tools and equipment. It also researches and promotes products through related companies throughout the world. The Group also produces food, food additives, livestock feeds, and agrochemicals.

Joji NakayamaPresident/CEOYuki SatoExecutive Vice President
Manabu SakaiExecutive Vice PresidentTakeshi OgitaSenior Managing Exec Officer
More Company Profile & Key Executives for D4S

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil